Resonance Health is looking for collaborators to trial a new MRI software tool developed by Resonance Health that uses artificial neural networks to measure liver iron concentration (LIC). The artificial neural networks have been trained on data from the Gold Standard FerriScan R2-MRI technology. The following survey will collect information on current radiology practices and suitable centres may have the opportunity to participate in a ground-breaking pilot study. All participants will receive a copy of the survey report.
This survey has the endorsement of the Thalassaemia International Federation. TIF have the following message:
"The Thalassaemia International Federation (TIF) focuses considerable interest in the accurate and reliable measurement and monitoring of iron load in the heart and liver as a means of contributing to the appropriate assessment of the effectiveness, particularly of the iron chelation therapy provided to each patient with transfusion dependent thalassaemia. Additionally reliable iron measurements are essential in the case of monitoring the progress of non-transfusion dependent thalassaemia for taking prompt and appropriate action in its management. In this context, TIF supports the efforts of Resonance Health in developing more economical ways to, equally reliably and effectively, measure iron deposits in vital organs of the body. Therefore, we kindly encourage you to complete this questionnaire."